Moneta Group Investment Advisors LLC Novartis Ag Transaction History

Moneta Group Investment Advisors LLC

$7.05 Billion
Q4 2024

A detailed history of Moneta Group Investment Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Moneta Group Investment Advisors LLC holds 3,375 shares of NVS stock, worth $374,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,375

Previous 3,338 1.11%

Holding current value

$374,928

Previous $383,000 14.36%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$96.78 - $117.18 $3,580 - $4,335	37 Added 1.11%	3,375 $328,000
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $323,484 - $368,472	3,048 Added 1051.03%	3,338 $383,000
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $17,866 - $20,722	-193 Reduced 39.96%	290 $30,000
Q1 2024 Aug 13, 2024	SELL	$95.27 - $108.47 $529,891 - $603,310	-5,562 Reduced 92.01%	483 $46,000
Q4 2023 Feb 15, 2024	SELL	$92.27 - $101.54 $16,793 - $18,480	-182 Reduced 2.92%	6,045 $610,000
Q3 2023 Nov 15, 2023	BUY	$94.73 - $105.13 $557,675 - $618,900	5,887 Added 1731.47%	6,227 $634,000
Q2 2023 Aug 15, 2023	SELL	$92.52 - $104.91 $554,657 - $628,935	-5,995 Reduced 94.63%	340 $34,000
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $117,884 - $136,709	1,473 Added 30.3%	6,335 $582,000
Q4 2022 Feb 16, 2023	BUY	$75.55 - $92.52 $25,687 - $31,456	340 Added 7.52%	4,862 $441,000
Q4 2022 Feb 16, 2023	SELL	$75.55 - $92.52 $341 Million - $418 Million	-4,517,535 Reduced 99.9%	4,522 $410,000
Q4 2022 Feb 15, 2023	BUY	$75.55 - $92.52 $341 Million - $418 Million	4,517,637 Added 102208.98%	4,522,057 $410 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $13,579 - $15,881	-182 Reduced 3.95%	4,420 $336,000
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $38,408 - $44,718	477 Added 11.56%	4,602 $389,000
Q1 2022 May 11, 2022	BUY	$80.11 - $90.62 $5,287 - $5,980	66 Added 1.63%	4,125 $362,000
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $131,584 - $145,502	-1,651 Reduced 28.91%	4,059 $355,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $195,372 - $227,289	2,389 Added 71.94%	5,710 $467,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $5,881 - $6,496	69 Added 2.12%	3,321 $303,000
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $60,203 - $70,996	721 Added 28.49%	3,252 $278,000
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $12,647 - $15,297	162 Added 6.84%	2,531 $239,000
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $6,489 - $7,189	79 Added 3.45%	2,369 $206,000
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $185,329 - $208,619	2,290 New	2,290 $200,000
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $25,319 - $27,900	-296 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$75.4 - $92.8 $185,031 - $227,731	-2,454 Reduced 89.24%	296 $27,000
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $184,202 - $226,710	2,443 Added 795.77%	2,750 $27,000
Q1 2019 May 16, 2019	SELL	$75.32 - $86.15 $81,044 - $92,697	-1,076 Reduced 77.8%	307 $26,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $104,167 - $119,145	1,383 New	1,383 $26,000
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $154,028 - $178,166	-2,301 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$64.91 - $73.36 $8.11 Million - $9.17 Million	-125,007 Reduced 98.19%	2,301 $174,000
Q2 2018 Aug 15, 2018	BUY	$64.91 - $73.36 $3,829 - $4,328	59 Added 0.05%	127,308 $174,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $8.26 Million - $9.33 Million	127,249 New	127,249 $173,000
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $377,290 - $451,044	-5,360 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $2,459 - $2,639	-34 Reduced 0.63%	5,360 $450,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $399,911 - $416,794	5,394	5,394 $463,000

Others Institutions Holding NVS

# of Institutions

1,478

Shares Held

130M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $239B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.

Account

Moneta Group Investment Advisors LLC Novartis Ag Transaction History